CancerNetwork® podcasts (ONCOLOGY® On The Go and OncView™ Podcast Edition) provide insightful and educational content from renowned multidisciplinary oncology experts regarding challenging treatment scenarios.
DLBCL Trials May Exclude Patients Who Need Novel Therapies Most
December 11th 2017In this interview we discuss how a short diagnosis-to-treatment interval in newly diagnosed diffuse large B-cell lymphoma is associated with worse outcomes and how this could lead to trials favoring patients with a longer diagnosis-to-treatment interval and better expected outcomes.
Incorporating Immunotherapy-Related Biomarkers Into Clinical Practice
June 9th 2017Dr. Karen Reckamp talks about ways to incorporate biomarkers for the treatment of lung cancer with immunotherapy into clinical practice at the 2017 American Society of Clinical Oncology Annual Meeting, held June 2–6 in Chicago.